Tyrosine kinase Etk/BMX protects nasopharyngeal carcinoma cells from apoptosis induced by radiation

Cancer Biology and Therapy

Volumn 11, Issue 7, 2011, Pages 690-698

  Zhang, Zhenhua ^a,b   Zhu, Weiliang ^a   Zhang, Jian ^a   Guo, Linlang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Southern Medical University   (China)

Author keywords

Apoptosis; Etk Bmx; Nasopharyngeal carcinoma; Radiation

Indexed keywords

BONE MARROW X KINASE; EPITHELIAL AND ENDOTHELIAL TYROSINE KINASE; PROTEIN P53; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENICITY; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INOCULATION; IRRADIATION; NASOPHARYNX CARCINOMA; UPREGULATION;

EID: 79953313816     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.7.15060     Document Type: Article

References (27)

1. Chan AT, Teo PM, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol 2002; 13:1007-15; PMID: 12176778; DOI: 10.1093/annonc/mdf179.
2. Fandi A, Cvitkovic E. Nasopharyngeal cancer: epidemiology, staging and treatment. Semin Oncol 1994; 21:382-97; PMID: 8209270.
3. Chang JT, Ko JY, Hong RL. Recent advances in the treatment of nasopharyngeal carcinoma. J Formos Med Assoc 2004; 103:496-510; PMID: 15318271.
4. DeNittis AS, Liu L, Rosenthal DI, Machtay M. Nasopharyngeal carcinoma treated with external radiotherapy, brachytherapy and concurrent/adjuvant chemotherapy. Am J Clin Oncol 2004; 25:93-5; PMID: 11823706.
5. Kim BY, Kim KA, Kwon O, Ha R, Oh WK, Kim MS, et al. NFκB inhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation. Carcinogenesis 2005; 26:1395-403; PMID: 15802300; DOI: 10.1093/carcin/bgi081.
6. Toulany M, Dittmann K, Baumann M, Rodemann HP. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS. Radiother Oncol 2005; 74:117-29; PMID: 15734199; DOI: 10.1016/j.radonc.2004.11.008.
7. Zhou H, Kim YS, Peletier A, McCall W, Earp HS, Sartor CI. Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization and resistance. Int J Radiat Oncol Biol Phys 2004; 58:344-52; PMID: 14751502; DOI: 10.1016/j.ijrobp.2003.09. 046.
8. Bristow RG, Benchimol S, Hill RP. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol 1996; 40:197-223; PMID: 8940748; DOI: 10.1016/0167-8140(96)01806-3.
9. Pirollo KF, Hao Z, Rait A, Ho CW, Chang EH. Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells. Biochem Biophys Res Commun 1997; 230:196-201; PMID: 9020045; DOI: 10.1006/bbrc.1996.5922.
10. Bussink J, Van der Kogel A, Kaander J. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol 2008; 9:288-96; PMID: 18308254; DOI: 10.1016/S1470-2045(08)70073- 1.
11. Chang JT, Chan SH, Lin CY, Lin TY, Wang HM, Liao CT, et al. Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther 2007; 6:2271-9; PMID: 17671084; DOI: 10.1158/1535-7163.MCT-06-0801.
12. Tamagnone L, Lahtinen I, Mustonen T, Virtaneva K, Francis F, Muscatelli F, et al. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 1994; 9:3683-8; PMID: 7970727.
13. Smith CI, Islam TC, Mattsson PT, Mohamed AJ, Nore BF, Vihinen M. The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays 2001; 23:436-46; PMID: 11340625; DOI: 10.1002/bies.1062.
14. Qiu Y, Kung HJ. Signaling network of the Btk family kinases. Oncogene 2000; 19:5651-61; PMID: 11114746; DOI: 10.1038/sj.onc.1203958.
15. Mano H. Tec family of protein-tyrosine kinases: an overview of their structure and function. Cytokine & Growth Factor Rev 1999; 10:267-80; PMID: 10647781; DOI: 10.1016/S1359-6101(99)00019-2.
16. Wen X, Lin HH, Shih HM, Kung HJ, Ann DK. Kinase activation of the non-receptor tyrosine kinase Etk/BMX alone is sufficient to transactivate STAT-mediated gene expression in salivary and lung epithelial cells. J Biol Chem 1999; 274:38204-10; PMID: 10608894; DOI: 10.1074/jbc.274.53.38204.
17. Robinson D, He F, Pretlow T, Kung HJ. A tyrosine kinase profile of prostate carcinoma. Proc Natl Acad Sci USA 1996; 93:5958-62; PMID: 8650201; DOI: 10.1073/pnas.93.12.5958.
18. Tsai Y, Su Y, Fang S, Huang T, Qiu Y, Jou Y, et al. Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation. Mol Cell Biol 2000; 20:2043-54; PMID: 10688651; DOI: 10.1128/MCB.20.6.2043-2054.2000.
19. Jiang T, Guo Z, Dai B, Kang M, Ann DK, Kung HJ, et al. Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage. J Biol Chem 2004; 279:50181-9; PMID: 15355990; DOI: 10.1074/jbc.M409108200.
20. Xue L, Qiu Y, He J, Kung HJ, Oleinick NL. Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin. Oncogene 1999; 18:3391-8; PMID: 10362360; DOI: 10.1038/sj.onc.1202687.
21. Guo L, Chen P, Zhou Y, Sun Y. Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells. Exp Mol Pathol 2010; 88:401-6; PMID: 20206622; DOI: 10.1016/j.yexmp.2010.02.003.
22. Guo L, Zhou Y, Sun Y, Zhang F. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer. Eur J Cancer 2010; 46:636-41; PMID: 20004564; DOI: 10.1016/j.ejca.2009.11.009.
23. Jameel JK, Rao VS, Cawkwell L, Drew PJ. Radioresistance in carcinoma of the breast. Breast 2004; 13:452-60; PMID: 15563851; DOI: 10.1016/j.breast.2004. 08.004.
24. Streffer JR, Rimner A, Rieger J, Naumann U, Rodemann HP, Weller M. BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells. J Neurooncol 2002; 56:43-9; PMID: 11949826.
25. Lee JU, Hosotani R, Wada M, Doi R, Kosiba T, Fujimoto K, et al. Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells. Eur J Cancer 1999; 35:1374-80; PMID: 10658530; DOI: 10.1016/S0959-8049(99)00134-3.
26. Norbury CJ, Hickson ID. Cellular response to DNA damage. Annu Rev Pharm Toxicol 2001; 41:367-401; PMID: 11264462; DOI: 10.1146/annurev.pharmtox.41.1. 367.
27. Jorgensen TJ. Enhancing radiosensitivity: targeting the DNA repair pathways. Cancer Biol Ther 2009; 8:665-70; PMID: 19287209; DOI: 10.4161/cbt.8.8.8304.